Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
CVS Health
CVS
Market cap
$102B
Overview
Fund Trends
Analyst Outlook
Journalist POV
79.90
USD
+1.89
2.42%
At close
Updated
Feb 27, 4:00 PM EST
Pre-market
After hours
79.76
-0.14
0.18%
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
2.42%
5 days
5.1%
1 month
10.97%
3 months
-0.57%
6 months
11.08%
Year to date
-0.29%
1 year
23.91%
5 years
15.33%
10 years
-17.77%
Upgrade to unlock
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
31.6%
Negative
Positive
Neutral
Negative
Positive
The Motley Fool
3 days ago
2 Top Healthcare Stocks to Buy in February
CVS Health is making changes that could improve its business this year. Vertex Pharmaceuticals should see strong commercial and clinical progress in 2026.
Positive
Zacks Investment Research
11 days ago
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Neutral
PRNewsWire
11 days ago
CVS Health Announces $5 Million Scholarship Program to Support Future Pharmacists in Louisiana
Investment aims to strengthen the pharmacy workforce and expand access to care across the state BATON ROUGE, La., Feb. 18, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced the launch of a new $5 million scholarship program designed to support aspiring pharmacists in the state of Louisiana.
Positive
Zacks Investment Research
12 days ago
Here's Why CVS Health (CVS) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Positive
Benzinga
12 days ago
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Positive
Zacks Investment Research
13 days ago
Here's Why CVS Health (CVS) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Neutral
GlobeNewsWire
16 days ago
Saggio Realty Announces Milestone Linked to Sale of Marco Island's CVS-Anchored Plaza
Mike Rivera Of Naples Fl Congratulates Hendricks Commercial Properties on Exceptional Return From Sale of Marco Island's CVS-Anchored Island Plaza Mike Rivera Of Naples Fl Congratulates Hendricks Commercial Properties on Exceptional Return From Sale of Marco Island's CVS-Anchored Island Plaza
Negative
Market Watch
17 days ago
These 32 favorite stocks signal the bull market is running on fumes
The S&P 500 sectors that top investment newsletters currently like most are strongest at market peaks.
Positive
Benzinga
18 days ago
Analysts See Multiple Growth Levers For CVS Health In 2026
CVS Health Corp. (NYSE: CVS) reported sales of $105.69 billion, beating the consensus of $103.59 billion on Tuesday.
Positive
Seeking Alpha
19 days ago
CVS Health: Why Margin Compression In Aetna Limits The Upside For 2026
CVS Health Corporation is rated a Hold, reflecting balanced risk and income potential amid persistent Medicare Advantage cost pressures. Q4 2025 saw record revenue, but rising medical costs in Aetna drove a $1B cut to FY 2026 cash flow guidance, now at $9B. CVS Health's valuation is highly sensitive to margin changes, with exposure to Medicare Advantage limiting upside barring significant CMS rate increases.
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close